Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognosis of Gleason Score 9–10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study

Published:2023-11 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Egevad Lars,Micoli Chiara,Samaratunga Hemamali,Delahunt Brett,Garmo Hans,Stattin Pär,Eklund Martin

Funder

Cancerfonden

Vetenskapsrådet

Uppsala Universitet

Cancerföreningen i Stockholm

Swedish Cancer Foundation

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference28 articles.

1. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system;Epstein;Am J Surg Pathol,2016

2. Prostate cancer grading, time to go back to the future;Egevad;BJU Int,2021

3. Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade grouping;Gandaglia;Urol Oncol,2017

4. Outcome of Gleason 3 + 5 = 8 prostate cancer diagnosed on needle biopsy: prognostic comparison with Gleason 4 + 4 = 8;Harding-Jackson;J Urol,2016

5. Gleason score 3 + 5 or 5 + 3 versus 4 + 4 prostate cancer: the risk of death;Huynh;Eur Urol,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patients ask and pathologists answer: ten questions around prostate cancer grading;Virchows Archiv;2024-08-17

2. Study Protocol: Development and Retrospective Validation of an Artificial Intelligence System for Diagnostic Assessment of Prostate Biopsies;2024-07-07

3. Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study;Virchows Archiv;2024-04-29

4. Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada;Human Pathology;2024-04

5. Significant Survival Differences for Grade Group 4 and Grade Group 5 Prostate Cancer: Detailed Reporting of Pathohistology and Modern Diagnostic Algorithms Are Needed To Tailor Treatment;European Urology Oncology;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3